**Question:** PNH is associated with all of the following conditions, except -

A. Hemolytic anemia
B. Thrombosis
C. Splenectomy
D. Infections

**Core Concept:**
PNH stands for Paroxysmal Nocturnal Hemoglobinuria, which is a rare blood disorder characterized by the destruction of red blood cells (hemolysis) due to the absence of membrane proteins on the cells. This leads to anemia, fatigue, and increased risk of thrombosis and infections. The condition is caused by mutations in the PIG-A gene, leading to the deficiency of glycosylphosphatidylinositol-anchored proteins on red blood cells.

**Why the Correct Answer is Right:**
PNH is characterized by hemolysis and increased susceptibility to infections, as the membrane proteins on red blood cells are absent. However, splenectomy is a surgical procedure to remove the spleen, which is responsible for filtering out damaged and abnormal red blood cells. As a result of splenectomy, the number of abnormal cells increases, leading to worsened hemolysis. Therefore, splenectomy is not a condition associated with PNH, making option C (splenectomy) the correct answer.

**Why Each Wrong Option is Incorrect:**

A. Hemolytic anemia is a core feature of PNH, resulting from the destruction of red blood cells due to the absence of membrane proteins. This makes option A (hemolytic anemia) incorrect.

B. Infections are a frequent complication in PNH due to the absence of complement regulatory proteins on the surface of red blood cells. This makes option B (thrombosis) incorrect.

D. Infections are a frequent complication in PNH, making option D (infections) incorrect. The increased susceptibility to infections is due to the deficiency of complement regulatory proteins on the surface of red blood cells, leading to uncontrolled activation of the classical complement pathway and subsequent inflammation and immune response.

**Clinical Pearl:**
PNH is a rare disorder with a prevalence of approximately 1 in 1 million people. Clinical management includes monitoring hemoglobin levels, managing anemia with erythropoietin, treating complications like thrombosis and infections, and considering hematopoietic stem cell transplantation as a curative treatment option. In patients with PNH, it is essential to differentiate between the conditions associated with the disease itself and those resulting from its complications. This helps in tailoring the appropriate management strategy for these patients.